BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 35857432)

  • 1. Advances, challenge and prospects in cell-mediated nanodrug delivery for cancer therapy: a review.
    Wei W; Zhang Y; Lin Z; Wu X; Fan W; Chen J
    J Drug Target; 2023 Jan; 31(1):1-13. PubMed ID: 35857432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems.
    Liu H; Zhu X; Wei Y; Song C; Wang Y
    Biomed Pharmacother; 2023 Jan; 157():114065. PubMed ID: 36481408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal clearable nanocarriers: Overcoming the physiological barriers for precise drug delivery and clearance.
    Peng C; Huang Y; Zheng J
    J Control Release; 2020 Jun; 322():64-80. PubMed ID: 32194171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in kidney-targeted drug delivery systems.
    Chen Z; Peng H; Zhang C
    Int J Pharm; 2020 Sep; 587():119679. PubMed ID: 32717283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ cellular hitchhiking of nanoparticles for drug delivery.
    Udofa E; Zhao Z
    Adv Drug Deliv Rev; 2024 Jan; 204():115143. PubMed ID: 38008185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.
    Babu A; Templeton AK; Munshi A; Ramesh R
    AAPS PharmSciTech; 2014 Jun; 15(3):709-21. PubMed ID: 24550101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress on the pathological tissue microenvironment barrier-modulated nanomedicine.
    Han H; Xing L; Chen BT; Liu Y; Zhou TJ; Wang Y; Zhang LF; Li L; Cho CS; Jiang HL
    Adv Drug Deliv Rev; 2023 Sep; 200():115051. PubMed ID: 37549848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid cell-mediated drug delivery: From nanomedicine to cell therapy.
    Zhang F; Xu Z; Jolly KJ
    Adv Drug Deliv Rev; 2023 Jun; 197():114827. PubMed ID: 37068659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing cells to deliver nanoparticle drugs to treat cancer.
    Singh B; Mitragotri S
    Biotechnol Adv; 2020; 42():107339. PubMed ID: 30639928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Application of Nanotechnology in the Codelivery of Active Constituents of Plants and Chemotherapeutics for Overcoming Physiological Barriers during Antitumor Treatment.
    Li Q; Xiong Y; Ji C; Yan Z
    Biomed Res Int; 2019; 2019():9083068. PubMed ID: 31915707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary delivery of nano-particles for lung cancer diagnosis and therapy: Recent advances and future prospects.
    A R; Han Z; Wang T; Zhu M; Zhou M; Sun X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(1):e1933. PubMed ID: 37857568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising Nanomedicines of Shikonin for Cancer Therapy.
    Yan C; Li Q; Sun Q; Yang L; Liu X; Zhao Y; Shi M; Li X; Luo K
    Int J Nanomedicine; 2023; 18():1195-1218. PubMed ID: 36926681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstacles and opportunities in a forward vision for cancer nanomedicine.
    de Lázaro I; Mooney DJ
    Nat Mater; 2021 Nov; 20(11):1469-1479. PubMed ID: 34226688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicines as cancer therapeutics: current status.
    Akhter S; Ahmad I; Ahmad MZ; Ramazani F; Singh A; Rahman Z; Ahmad FJ; Storm G; Kok RJ
    Curr Cancer Drug Targets; 2013 May; 13(4):362-78. PubMed ID: 23517593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research progress on self-assembled nanodrug delivery systems.
    Qiao L; Yang H; Gao S; Li L; Fu X; Wei Q
    J Mater Chem B; 2022 Mar; 10(12):1908-1922. PubMed ID: 35212343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
    Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
    J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Delivery in Cancer Therapy, Quo Vadis?
    Lu ZR; Qiao P
    Mol Pharm; 2018 Sep; 15(9):3603-3616. PubMed ID: 29553749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Big Data Analysis of Manufacturing and Preclinical Studies of Nanodrug-Targeted Delivery Systems: A Literature Review.
    Cao Q; Li X; Zhang Q; Zhou K; Yu Y; He Z; Xiang Z; Qiang Y; Qi W
    Biomed Res Int; 2022; 2022():1231446. PubMed ID: 35941977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
    Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
    Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.